Mamotest
PrivateLast Round
Early Funding
Mar 27, 2023
Total Funding Raised
$4.9M
Company Overview
Mamotest operates in Healthcare & Life Sciences and is based in Buenos Aires. Its latest recorded funding round was an Early Funding round in March 2023.
Mamotest is a healthtech company that provides an AI-powered telemammography network and patient navigation platform to improve access to early breast cancer diagnosis and treatment.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Telemedicine, Patient Engagement
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mamotest Comparables
Compare Mamotest with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Therapixel | 76% | |
| CureMetrix | 76% | |
| Qure.ai | 70% |
For institutional investors. Book with your work email.
Mamotest Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 27, 2023 | ||||
| Seed | Jun 6, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Mamotest Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sonen Capital | Early Funding |
| Sky High VC | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2026
Monthly visitors increased 185% MoM, reaching 539.
For institutional investors. Book with your work email.
Mamotest Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mamotest's valuation, stock price, and market status.
Is Mamotest a public or private company?
Mamotest is a private company.
What is the current stock price of Mamotest?
Mamotest is a private company, so its shares have no public market price. Caplight tracks Mamotest's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mamotest worth (valuation)?
Valuation information for Mamotest is not publicly available.
Can I buy Mamotest stock?
Mamotest shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mamotest's last funding round?
Mamotest's most recent funding round was Early Funding on March 27, 2023.
Who are the main investors in Mamotest?
Key investors in Mamotest include Sonen Capital, Sky High VC.
Will Mamotest IPO soon?
No public IPO plans have been announced for Mamotest.
How can I track Mamotest secondary market activity?
Caplight tracks bids, offers, and trades in Mamotest's shares on secondary markets.